@article{discovery1411978,
           month = {January},
          volume = {7},
          number = {6},
           pages = {--},
            note = {{\copyright} 2012 Palmqvist et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMCID: PMC3382225},
           title = {Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study},
         journal = {PLoS One},
            year = {2012},
        keywords = {Aged, Aged, 80 and over, Alzheimer Disease, Amyloid beta-Peptides, Biological Markers, Cognition Disorders, Dementia, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mild Cognitive Impairment, Neuropsychological Tests, ROC Curve, tau Proteins},
            issn = {1932-6203},
             url = {http://dx.doi.org/10.1371/journal.pone.0038639},
          author = {Palmqvist, S and Hertze, J and Minthon, L and Wattmo, C and Zetterberg, H and Blennow, K and Londos, E and Hansson, O},
        abstract = {Early identification of Alzheimer's disease (AD) is needed both for clinical trials and in clinical practice. In this study, we compared brief cognitive tests and cerebrospinal fluid (CSF) biomarkers in predicting conversion from mild cognitive impairment (MCI) to AD.}
}